IMP: Report on the use of capital
Imexpharm Pharmaceutical Joint Stock Company reported the use of the proceeds from stock offering:
- Total proceeds from the offering: VND98,201,510,000 (or 3,554,680 shares)
- The capital used until April 12, 2012: VND89,853 million, including:
- Paying for Penicillin injection production line: VND37,293 million.
- Paying for upgrading equipment for Cao Lanh Factory: VND10 billion.
- Investing in system distribution: VND32,560 million.
- Raising the working capital: VND10 billion.
hose
|